Characterization of norbelladine synthase and noroxomaritidine/norcraugsodine reductase reveals a novel catalytic route for the biosynthesis of Amaryllidaceae alkaloids including the Alzheimer’s drug galanthamine
Amaryllidaceae alkaloids (AAs) are a large group of plant specialized metabolites with diverse pharmacological properties. Norbelladine is the entry compound in AAs biosynthesis and is produced from the condensation of tyramine and 3,4-dihydroxybenzaldehyde (3,4-DHBA). There are two reported enzymes...
Main Authors: | Bharat Bhusan Majhi, Sarah-Eve Gélinas, Natacha Mérindol, Simon Ricard, Isabel Desgagné-Penix |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Plant Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpls.2023.1231809/full |
Similar Items
-
Cloning and characterization of norbelladine synthase catalyzing the first committed reaction in Amaryllidaceae alkaloid biosynthesis
by: Aparna Singh, et al.
Published: (2018-12-01) -
Chemical Synthesis and Biological Activities of Amaryllidaceae Alkaloid Norbelladine Derivatives and Precursors
by: Marie-Pierre Girard, et al.
Published: (2022-08-01) -
Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies
by: Abdullah Al Mamun, et al.
Published: (2021-08-01) -
Biosynthesis and Biological Activities of Newly Discovered Amaryllidaceae Alkaloids
by: Seydou Ka, et al.
Published: (2020-10-01) -
Preparation of Shortened Norbelladine Analogs
by: Ulrich Jordis, et al.
Published: (2002-10-01)